Melatonin (Topical, skin-antioxidant context)
Topical melatonin is a newer skincare ingredient that uses the same molecule the body normally makes for sleep — but applied to the skin in a cream or serum, where it works as an antioxidant rather than affecting sleep. It does NOT make you drowsy. Important to know: oral melatonin (taken as a pill or capsule for sleep) is a UK Prescription-Only Medicine — Circadin and Slenyto. It is NOT available over the counter in the UK. Topical melatonin in a skincare cream is a completely different product in a completely different regulatory tier; the only thing they share is the name. Pregnancy and breastfeeding: defer. There isn't enough safety data at supplement doses, so the conservative position is to avoid until you've finished breastfeeding. Vitamin C topical and niacinamide are better-established pregnancy-compatible antioxidant alternatives. Talk to your midwife or GP if uncertain.
Camden Medicals editorial · Last reviewed 6 May 2026 · Next review November 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Amino acid
- Typical daily dose
- 0.5-1% topical melatonin in evening serum or moisturiser. Often combined with vitamin E and / or ferulic acid.
- Top use evidence
- Strong
On this page
What it is
Melatonin is best known as the body's sleep hormone — it rises in the evening and signals to the body that it's time to wind down. What's less well-known is that skin cells make their own melatonin locally, where it works as a built-in antioxidant. Topical melatonin in a skincare product is a way to top up that local skin-surface antioxidant pool.
Crucially: applying melatonin to your skin does not make you drowsy. The amount that gets absorbed into the bloodstream from a thin layer of skincare is tiny — orders of magnitude below the dose used in sleep medication. The two contexts (skincare vs sleep) are completely separate.
The UK products you'll see most:
- ISDIN Melatonik Night Serum — Spanish dermatology brand; melatonin combined with bakuchiol and vitamin C
- Skinceuticals A.G.E. Eye Complex — small melatonin content alongside blueberry extract
- Restorsea Pro Reborn — melatonin with enzyme actives
A regulatory note worth knowing: oral melatonin is widely available over-the-counter as a sleep supplement in the US and many EU countries, but NOT in the UK — UK regulators classify it as a Prescription-Only Medicine (Circadin for adults over 55 with primary insomnia; Slenyto for some paediatric sleep contexts). If you've seen US content about melatonin for sleep, the UK rules are different. Talk to your GP about sleep concerns — the UK NHS pathway starts with sleep hygiene and CBT for insomnia.
At a glance
- Cosmetic ingredient applied to skin — NOT a sleep aid. Does not cause drowsiness.
- Different product entirely from oral melatonin (UK Prescription-Only as Circadin / Slenyto). Do not assume cross-over.
- Pregnancy and breastfeeding: defer. Use vitamin C topical or niacinamide instead — both are well-established pregnancy-compatible alternatives.
- Evening application typical, often paired with vitamin E or vitamin C. Pair with daytime SPF.
- UK brands you'll see: ISDIN Melatonik, Skinceuticals A.G.E. Eye Complex, Restorsea Pro Reborn.
- Trial evidence is smaller than retinol or vitamin C topical — emerging rather than well-established. Best treated as an antioxidant adjunct, not a primary skincare active.
What people use it for
Adults wanting evening antioxidant complement to AM vitamin C
Topical melatonin 0.5-1% applied PM may modestly support skin antioxidant capacity overnight. Trial evidence small. Pair with vitamin E and / or ferulic acid for synergistic antioxidant cluster.
Some evidenceLimitedAdults seeking pregnancy-safe topical-active alternative
Topical melatonin pregnancy contraindication is not formally established but precautionary avoidance is reasonable given limited human pregnancy data. Vitamin C topical and niacinamide are better-established pregnancy-safe alternatives. [7]
Popular, not provenInsufficientAdults considering oral melatonin for sleep
Oral melatonin in the UK is Prescription-Only (Circadin / Slenyto). Talk to GP. UK NICE CKS Insomnia pathway is sleep hygiene + CBTi first-line. Camden l-tryptophan covers the serotonin-melatonin precursor pathway and Camden valerian the THR-registered herbal sleep alternative. [2]
Some evidenceStrong
How it works
Skin spends most of its days fighting off oxygen-radical damage — from UV exposure, pollution, and just the everyday metabolism of skin cells. Antioxidants in skincare neutralise these radicals before they damage cell structures.
Vitamin C is a water-soluble antioxidant that works mainly in the watery parts of cells. Melatonin is a fat-soluble antioxidant that works mainly in the fatty parts (cell membranes, the mitochondria inside cells). This is why you'll see them combined in some products — they cover different chemical territory.
Melatonin also has a small "cascade" property: when it reacts with one radical, the by-product is itself still antioxidant — so one molecule can neutralise several radicals before it's used up. This sets it apart from vitamin C, which is one-and-done. In trial settings, topical melatonin applied before UV exposure has shown modest protection against UV damage markers, but the trial evidence is still small compared to retinol or vitamin C, and effects are modest.
Why it's an evening application: skin's own antioxidant production has a daily rhythm, lower at night. Applying melatonin in the evening lines up with when the skin's natural pool is at its lowest. There's no harm in morning application but the standard pattern is PM.
Common myths
Myth""Topical melatonin makes you sleepy.""
RealityTopical melatonin systemic absorption is low. Cosmetic-formulation topical melatonin does not produce sleep-promoting effects of oral melatonin. The systemic context is unrelated to topical cosmetic use.
Myth""You can use topical melatonin instead of taking oral melatonin for sleep.""
RealityTopical and oral melatonin are different clinical contexts. Topical is local antioxidant + skin-barrier signalling; oral (UK POM Circadin / Slenyto) is systemic circadian-rhythm regulation. UK NICE CKS Insomnia pathway is sleep hygiene + CBTi; oral melatonin via GP only. [2]
Myth""Topical melatonin is safe in pregnancy because it's natural.""
RealityNaturalness-as-safety arguments do not apply. Topical melatonin pregnancy contraindication is not formally established but precautionary avoidance is reasonable. Vitamin C topical and niacinamide are better-established pregnancy-safe alternatives.
What people say online
Topical melatonin is a smaller but growing search cluster on TikTok (#melatoninserum, #isdin, #ageingskin) and Reddit (r/SkincareAddiction). UK consumer discourse is particularly complicated by the UK oral melatonin POM status — UK users sometimes confuse cosmetic topical with the sleep-aid oral context, while US-clinic content frequently conflates the two. The dominant narratives are: (1) "topical melatonin = sleep patch / aid" confusion; (2) ISDIN Melatonik / Skinceuticals AGE Eye Complex product comparisons; (3) pregnancy-safety uncertainty. This section surfaces the discourse without naming individuals.
Trending claims
- TikTok (oral-topical confusion content)high visibility
Claim: Topical melatonin works like a sleep patch
Reality check: NO. Topical melatonin systemic absorption is low and cosmetic-formulation topical melatonin does NOT produce sleep-promoting effects of oral melatonin (UK POM Circadin / Slenyto). The two are different regulatory tiers, different clinical contexts. For sleep concerns, talk to your GP about the NICE CKS Insomnia pathway (sleep hygiene + CBTi first, POM melatonin only via prescription). [2]
- TikTok + Reddit (UK regulatory-workaround content)medium visibility
Claim: Use topical melatonin instead of oral melatonin to avoid the prescription
Reality check: NOT a workaround. Topical melatonin systemic absorption is low and does NOT produce the systemic circadian-rhythm regulation that oral melatonin provides. The UK POM status for oral melatonin reflects clinical-indication regulation, not consumer-access difficulty. Topical and oral are different products doing different things.
- TikTok (natural-safety content)medium visibility
Claim: Topical melatonin is safe in pregnancy because it is natural
Reality check: Naturalness-as-safety arguments do not apply. Topical melatonin pregnancy contraindication is not formally established but precautionary avoidance is reasonable given limited human pregnancy data. Vitamin C topical and niacinamide are better-established pregnancy-compatible alternatives. Talk to your midwife or GP if you are uncertain.
- TikTok (photoprotection-overstatement content)medium visibility
Claim: Topical melatonin replaces sunscreen
Reality check: NO. Topical melatonin is an antioxidant adjunct to sunscreen, not a replacement. Effect on UV-induced damage is smaller than broad-spectrum sunscreen and complements rather than substitutes. The trial evidence (Morreale 1997 + Morganti 2012) supports antioxidant adjunct role, not primary UV protection. [5]
Where the conversation lives
- TikTok hashtags: #melatoninserum, #isdin, #isdinmelatonik, #skinceuticals
- Reddit subs: r/SkincareAddiction, r/30PlusSkinCare, r/AsianBeauty
- Forums: Beautypedia, INCI Decoder
Questions people are searching
- Is topical melatonin the same as the sleep pill?
- Can I use topical melatonin in pregnancy?
- Does ISDIN Melatonik really work?
- Topical melatonin vs vitamin C — which is better?
- Can I use topical melatonin AM as well as PM?
Who drives the discourse: The discourse is driven by three influencer classes: cosmetic- chemist creators (most evidence-anchored on the lipophilic antioxidant mechanism + UK oral POM context); brand-affiliated creators (highest reach, particularly ISDIN + Skinceuticals collaborations); and dermatology doctor creators (clinical context including the UK POM regulatory distinction). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Melatonin (Topical, skin-antioxidant context). Each answer is editorial and links to its evidence in the Sources list below.
Is topical melatonin the same as oral melatonin?
No — distinct contexts. Topical is cosmetic-tier antioxidant; oral is UK POM Circadin / Slenyto for circadian-rhythm regulation. Read the label.
Does topical melatonin help with sleep?
No — topical melatonin systemic absorption is low and does not produce sleep-promoting effects. For sleep concerns, see Camden valerian or talk to GP about prescription oral melatonin pathway. [2]
Can I use topical melatonin in pregnancy?
Precautionary avoidance recommended despite low systemic absorption from topical application. Vitamin C topical and niacinamide are better-established pregnancy-safe alternatives.
UK regulatory landscape
UK regulatory tier: Cosmetic product
Topical melatonin is regulated under the UK Cosmetic Products Regulation (assimilated EU 1223/2009 + Cosmetic Products Enforcement Regulations 2013). The 2024 EU Cosmetic Regulation 2024/996 does NOT impose concentration caps on melatonin. The regulatory distinction from oral melatonin is fundamental: oral melatonin in the UK is a Prescription-Only Medicine (Circadin® prolonged-release 2 mg for primary insomnia in adults aged 55+; Slenyto® for paediatric autism / Smith-Magenis syndrome sleep difficulty) — NOT available over-the-counter in the UK as a food supplement. Cosmetic regulation requires CPSR, CPNP submission, and GMP cosmetic manufacture.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing as a sleep aid or for circadian-rhythm regulation | Crosses to medicinal claims; MHRA Borderline Section may classify as a medicinal product requiring product licence. Oral melatonin context is UK POM territory entirely. |
| Marketing as a substitute for prescription oral melatonin | Outside trial-evidence boundaries; distinct clinical contexts; ASA / CAP §12 enforcement. |
| Marketing as pregnancy-safe | Outside formal evidence base; precautionary universal avoidance per UK skincare convention. |
Permitted claims
Cosmetic claims must be substantiated per UK Cosmetic Claims Regulation. Permitted: descriptive ingredient claims, antioxidant cosmetic benefits, photoaging-marker improvements (modest). NOT permitted: sleep-aid claims, circadian-regulation claims, oral-medicine-equivalence framing.
Cross-jurisdiction note
Oral melatonin is widely available over-the-counter as a food supplement in the US and many European countries (not UK). UK consumers travelling abroad sometimes purchase oral melatonin and bring it back — this is a separate regulatory context from topical cosmetic use. US-clinic content about oral melatonin does NOT translate to UK consumer access.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Skin antioxidant capacity / photoprotection
LimitedEvidencelimitedFischer 2008 review and subsequent small RCTs supported modest photoprotective effects of topical melatonin. Effect size smaller than sunscreen.
Photoaging markers
LimitedEvidencelimitedSmall RCTs of topical melatonin in cosmetic formulations supported modest fine-line and texture improvements over 12-24 weeks. [3]
Post-procedure skin recovery
LimitedEvidencelimitedSmall adjunct trials in laser / chemical peel post-procedure recovery supported topical melatonin reducing erythema and accelerating healing.
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| UV photoprotection adjunct | adults | 0.5–1 | 4–12 wk | LimitedEvidencelimited | improvement | PMID 22456780 PMID 9305527 |
| Dose: 0.5-1% in evening serum or moisturiser, often combined with vitamin E + ferulic acid. Morganti 2012 (n=70, 12 weeks, placebo-controlled multicentre) — melatonin + vitamin E + beta-glucan complex (MEB) topical + oral produced significant improvements (p<0.005) in hydration, superficial lipids, elasticity, lipid peroxidation, and global appearance vs placebo. Trial cannot isolate melatonin contribution from combination effect. Mechanism foundation in Morreale 1997 lipid-bilayer + skin-homogenate antioxidant work. | ||||||
| Photoaging (hydration, elasticity, lipid peroxidation) | adults | 0.5–1 | 12 wk | LimitedEvidencelimited | improvement | PMID 22456780 |
| Morganti 2012 documented significant photoaging-marker improvements at 12 weeks; results visible from week 4. Effect is combination-product specific (melatonin alone trials are rare). Trial is industry-sponsored (Mavi Sud). UK-specific clinical-outcome data essentially absent. Treat as exploratory cosmetic-active rather than established efficacy. | ||||||
| Pregnancy topical melatonin exposure (precautionary avoidance) | pregnancy | — | — | InsufficientEvidenceinsufficient | not assessed | — |
| PRECAUTIONARY UNIVERSAL AVOIDANCE. Topical melatonin clinical pregnancy / lactation data is effectively absent. Oral melatonin is UK POM (Circadin / Slenyto) so a precautionary parallel applies to the cosmetic-tier topical despite low systemic absorption. Vitamin C topical + niacinamide are pregnancy-safe alternatives. Convention B3 safety-only row. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
The topical melatonin literature is smaller than the retinol or vitamin-C-topical evidence bodies — sitting in the mechanism + small-trial / case-series segment. The Morreale & Livrea 1997 foundational paper (Biochem Mol Biol Int, PMID 9305527) established the synergistic antioxidant interaction between melatonin, alpha-tocopherol, and glycolic acid in lipid bilayers and human skin homogenates — a foundational reference for the melatonin-vitamin-E pairing seen in modern UK skincare formulations. The Morganti et al. 2012 RCT (J Nutr Health Aging, PMID 22456780) tested melatonin + vitamin E + beta-glucan with chitin nanocrystals topically and orally in n=70 healthy subjects with photoaging over 12 weeks, finding significant improvements in hydration, lipid peroxidation, and clinical photoaging markers. The Morganti et al. 2002 antioxidant / photoprotection trial (Int J Cosmet Sci, PMID 18494887) is another small-n early study confirming topical melatonin's antioxidant role. Mechanism papers from the Slominski group established the "melatoninergic skin system" (skin-local melatonin synthesis in keratinocytes / melanocytes / hair follicles). Structural weakness: most trials are small (n<70), industry-sponsored, and formulation-combination-specific rather than melatonin-alone.
Key trials
Morganti P et al. · 2012 · J Nutr Health Aging · PMID 22456780
Finding: Melatonin + vitamin E + beta-glucan complex (MEB) with chitin nanocrystals applied topically AND orally vs placebo in healthy photoaging subjects. Significant improvements (p<0.005) across skin hydration, superficial lipids, elasticity, lipid peroxidation, and global clinical appearance vs placebo. Values higher when actives complexed with chitin nanocrystals. Results visible from week 4. No side effects.
Relevance: Largest melatonin-containing topical+oral RCT to date. Validates the melatonin + vitamin E + beta-glucan combination strategy and provides clinical-outcome evidence beyond pure mechanism work.
Morreale M, Livrea MA · 1997 · Biochem Mol Biol Int · PMID 9305527
Finding: Glycolic acid synergistically potentiated antioxidant activity of alpha-tocopherol and melatonin in liposomes and human skin homogenates. Vitamin E + glycolic acid showed up to 250% synergistic protection; melatonin + glycolic acid showed up to 80% synergism. The combination of vitamin E + melatonin + glycolic acid inhibited thiobarbituric-acid-reactive-substance (TBARS) production almost completely.
Relevance: Foundational mechanism paper for the melatonin-vitamin-E- ferulic / melatonin-vitamin-E-glycolic-acid antioxidant cluster. Anchor reference explaining why modern UK skincare formulations combine melatonin with vitamin E and ferulic acid (also a hydroxycinnamic acid like glycolic acid is related to AHA biochemistry).
Evidence quality summary
Topical melatonin antioxidant capacity — MODERATE-mechanism / LIMITED-clinical certainty (well-established lipophilic antioxidant mechanism; clinical trial evidence small and formulation-specific). Photoprotection adjunct — LIMITED certainty. Photoaging marker improvement — LIMITED certainty. Combination with vitamin E + glycolic acid / ferulic acid — MODERATE-mechanism certainty (Morreale 1997 + Morganti 2012). Pregnancy safety — INSUFFICIENT data (no documented teratogenic outcomes; precautionary universal avoidance given limited human data). Distinct from oral POM context — established by regulatory framework, not clinical-data dispute.
Known gaps
- No large independent (non-industry-sponsored) RCTs of topical melatonin alone.
- No head-to-head RCTs comparing topical melatonin vs vitamin C topical or vs vitamin E topical for matched-endpoint photoaging outcomes.
- UK-specific clinical-outcome data essentially absent — most trials are Italian (Morganti / Mavi Sud), Spanish (ISDIN), or US.
- Pregnancy / lactation topical melatonin data effectively absent (precautionary universal avoidance limits controlled trials).
- Long-term (>6 month) outcome data limited.
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Topical melatonin emerging cosmetic active. Avoid systemic-melatonin clinical-context conflation.
Talk to your pharmacist or GP first if you:
- You take oral melatonin (Circadin / Slenyto) — systemic context separate; topical use does not duplicate.
- You are pregnant or breastfeeding — precautionary avoidance reasonable.
Common side effects: Generally well-tolerated. Mild irritation possible.
Pregnancy and breastfeeding
Topical melatonin pregnancy contraindication is not formally established but precautionary avoidance is reasonable given limited human pregnancy data. Topical absorption is low; systemic exposure is minimal at cosmetic doses. Vitamin C topical and niacinamide are better-established pregnancy- compatible alternatives if antioxidant or photoaging support is the concern. Talk to your midwife or GP if you are uncertain.
Same precautionary position as pregnancy. Talk to your midwife or GP about pregnancy-compatible alternatives (vitamin C topical, niacinamide, hyaluronic acid).
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Hypersensitivity to melatonin or formulation constituents.
Drug interactions
Oral melatonin (UK POM Circadin, Slenyto) · theoretical
Effect: Theoretical additive systemic melatonin load if topical absorption is non-zero AND oral melatonin is prescribed; in practice topical systemic absorption is low. Mention to prescriber as a courtesy.
Mechanism: Topical melatonin systemic absorption is low; combined with prescription oral melatonin the theoretical additive load is clinically unlikely to matter.
Action: Tell your GP or prescribing clinician if you take oral melatonin (Circadin / Slenyto) and also use topical melatonin cosmetic products.
Source: BNF melatonin monograph
CYP1A2 substrates (caffeine, theophylline) and CYP2C19 inducers · theoretical
Effect: Theoretical at topical doses; systemic absorption from topical cosmetic use is too low to meaningfully affect hepatic CYP metabolism in most contexts.
Mechanism: Oral melatonin is partly metabolised by CYP1A2; this is relevant for oral POM context, not topical cosmetic use.
Action: Talk to your pharmacist if you take CYP-affecting medications and want to use topical melatonin cosmetic products.
Source: BNF melatonin monograph + CYP interactions
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Generally well-tolerated.
Rare side effects
- Contact dermatitis (rare).
How to take it
- Typical supplemental range
- 0.5-1% topical melatonin in evening serum or moisturiser. Often combined with vitamin E and / or ferulic acid.
- Timing
- Evening application typical. Pair with sunscreen-protected daytime routine.
How to spot quality
Look for
- Melatonin percentage clearly stated.
- Lipophilic / encapsulated formulation declared (melatonin is poorly water-soluble).
- Combined with vitamin E and / or ferulic acid for antioxidant synergy.
- Airless / opaque packaging — melatonin is photolabile.
Red flags
- Marketing as a sleep aid — outside topical-cosmetic context.
- Marketing as a substitute for oral melatonin — different clinical context.
- "Safe in pregnancy" — outside formal evidence base.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Vitamin C topical (L-ascorbic acid + ester derivatives)
Limited evidenceAntioxidant cluster — water-soluble (vitamin C) + lipid-soluble (melatonin) complementary mechanisms.
Vitamin C scavenges aqueous-phase ROS; melatonin scavenges lipid-phase ROS in cell membranes and mitochondria. Mechanism-complementary across redox compartments.
Evidence: Each component has individual trial body; combination not directly trialled.
Doses studied: AM: vitamin C 10-20%. PM: melatonin 0.5-1%.
Vitamin E (alpha-tocopherol)
Limited evidenceLipophilic-antioxidant cluster sibling.
α-tocopherol scavenges lipid peroxyl radicals; melatonin scavenges multiple lipid-phase ROS species + cyclic 3-hydroxymelatonin cascade. Mechanism-additive on lipid-membrane antioxidant axis.
Evidence: Mechanism complementary; co-formulation common. [4]
Doses studied: PM: 0.5-1% melatonin + 1-2% α-tocopherol.
Retinol (Vitamin A1, all-trans-retinol)
Limited evidenceMechanism-complementary anti-photoaging PM cluster.
Retinol nuclear-receptor remodelling + melatonin antioxidant + circadian-barrier signalling. Different axes; both PM applications.
Evidence: Mechanism complementary; combination trials small.
Doses studied: PM: melatonin serum + retinol 0.2-0.5% layered or alternated.
L-Tryptophan
Limited evidenceSystemic precursor pathway — l-tryptophan → 5-HTP → serotonin → melatonin.
L-tryptophan is the upstream amino-acid precursor for endogenous melatonin synthesis (pineal + skin melatoninergic systems). Topical melatonin supplements local skin pool. Different contexts; both feed the melatoninergic system.
Evidence: Mechanism well-established; combination not directly trialled in skin context.
Doses studied: Topical melatonin 0.5-1% PM + oral l-tryptophan 500-1000 mg PM (Camden l-tryptophan covers the serotonin-syndrome warning list).
Niacinamide (Topical, Vitamin B3 amide form)
Limited evidenceBarrier-rebuild + antioxidant cluster.
Niacinamide ceramide / FFA synthesis + anti-inflammatory; melatonin antioxidant + circadian barrier signalling. Mechanism-complementary on barrier + redox axes.
Evidence: Mechanism complementary; combination trials small.
Doses studied: PM: niacinamide → melatonin → moisturiser.
Verifera™ editorial perspective
Why it matters. Topical melatonin is an emerging cosmetic active where UK consumer confusion is high because the oral form is a UK Prescription-Only Medicine (Circadin® / Slenyto®). The Verifera editorial position is that this entry must unmistakably distinguish the topical cosmetic context from the oral POM context, and anchor the precautionary pregnancy framing.
Where Camden lands. Camden Medicals does NOT retail topical melatonin or oral melatonin (POM, prescriber-only in UK). Camden retails oral food supplements in the broader sleep / serotonin precursor cluster (Camden l-tryptophan, valerian). This entry exists as a UK- anchored reference for consumers researching topical melatonin alongside the broader topical antioxidant cluster.
If you want to explore further. For UK consumers researching the topical cosmetic context: the NHS skincare and pregnancy pages are entry points. For sleep concerns (the oral context), the NHS NICE CKS Insomnia pathway starts with sleep hygiene + CBTi; oral melatonin Circadin / Slenyto is GP-prescribed. Talk to your midwife or GP about pregnancy-compatible alternatives if topical antioxidants are the concern.
How this entry was researched
Authoritative sources consulted:
- NHS conditions pages (insomnia, pregnancy)
- NICE CKS Insomnia clinical knowledge summary
- BNF melatonin monograph (Circadin / Slenyto context)
- EU Cosmetic Regulation 1223/2009 + UK Cosmetic Products Enforcement Regulations 2013
- PubMed (via E-utilities MCP)
PubMed search terms:
topical melatonin skin antioxidant photoaging
Literature search date: 2026-05-11
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.